Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B2POB8
|
|||
| Binder Name |
Fraxin
|
|||
| Synonyms |
Fraxetin-8-O-glucoside; FRAXINE; UNII-V7M270Y072; 2H-1-Benzopyran-2-one, 8-(beta-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-; V7M270Y072; 8-(beta-D-Glucopyranosyloxy)-7-hydroxy-6-methoxy-2H-1-benzopyran-2-one; paviin; MFCD00010093; C16H18O10; EINECS 208-355-5; Fraxin;Fraxoside; Paviin; Fraxin, analytical standard; MLS002473090; fraxetin-8-O-beta-D-glucoside; CHEMBL293864; MEGxp0_000484; SCHEMBL1227439; ACon1_000325; DTXSID30200410; fraxetin-8-beta-D-glucopyranoside; HMS2225L24; HY-N0579; ZINC4027246; fraxetin-8-O-beta-D-glucopyranoside; BDBM50428429; s9296; AKOS037514646; CCG-268292; MCULE-3801558632; NCGC00169184-01; SMR001397192; CS-0009114; N1957; X1139; 524F301; Q-100594; Q1452081; BRD-K31984062-001-01-6; 8-(beta-d-glucopyranosyloxy)-7-hydroxy-6-methoxycoumarin; 7-hydroxy-6-methoxy-2-oxo-2H-chromen-8-yl beta-D-glucopyranoside; METHYL3,3,3-TRIFLUORO-2-[2,2,2-TRIFLUORO-ACETYLIMINO]PROPIONATE; 2H-1-Benzopyran-2-one, 8-(.beta.-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H18O10
|
|||
| Canonical SMILES |
COC1=C(C(=C2C(=C1)C=CC(=O)O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O
|
|||
| InChI |
1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s1
|
|||
| InChIKey |
CRSFLLTWRCYNNX-QBNNUVSCSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:5170
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.